Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function-Reference-Cited by-同舟云学术

Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function

Published:2016-03-24 Issue:6 Volume:36 Page:807-816
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Saxena Varun¹,Koraishy Farrukh M.²,Sise Meghan E.³,Lim Joseph K.⁴,Schmidt Monica⁵,Chung Raymond T.³,Liapakis Annmarie⁴,Nelson David R.⁶,Fried Michael W.⁵,Terrault Norah A.¹,

Affiliation:

1. University of California San Francisco; San Francisco CA USA

2. Saint Louis University School of Medicine; St Louis MO USA

3. Massachusetts General Hospital; Boston MA USA

4. Yale University School of Medicine; New Haven CT USA

5. University of North Carolina; Chapel Hill NC USA

6. University of Florida; Gainesville FL USA

Funder

University of Florida

University of North Carolina at Chapel Hill

AbbVie

Bristol-Myers Squibb

Gilead Sciences

Janssen

Kadmon

Merck

Vertex

CTSA UF

National Institutes of Health

UCSF Liver Center member

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13102/fullpdf

Reference22 articles.

1. AASLD/IDSA/IAS-USA Recommendations for testing, managing, and treating hepatitis C http://www.hcvguidelines.org

2. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease;Tsui;Arch Intern Med,2007

3. Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET;Gordon;J Hepatol,2015

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

2. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review;Liver International;2024-02-22

3. Treatment of chronic viral hepatitis c in perm Krai;Perm Medical Journal;2024-01-22

4. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

5. The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study;Clinics and Research in Hepatology and Gastroenterology;2023-12